Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
Studies on radiation induced patients' skin lesions in interventional radiology highlighted the need for optimized and personalized patient dosimetry and adapted patient follow-up. Measurements using Gafchromic® films or thermoluminescent dosimeters have long been the only way to accurately evaluate the maximum absorbed dose to the patient skin. However as these dose measurements are tedious and expensive, they could not be systematically applicable in clinical practice. Therefore, more practical calculation methods have been developed. These software programs calculate the skin dose using dosimetric information from images DICOM header or radiation dose structured reports (RDSRs). Validation studies of these software programs are rare and when existent have many limitations.
Radiation Dose Monitor (RDM from Medsquare) is a software program for archiving and monitoring of radiation dose (DACS, Dosimetry Archiving Communication System) used in routine in the investigator's hospitals. A new functionality developed in RDM allows quick estimation without in-vivo measurements of the absorbed dose to the skin of the patient. Comparing RDM calculations with in-vivo measurements will enable this software validation so that it can be used in clinical routine.
Main objective: to validate RDM software for calculating patient skin dose in interventional radiology.
Full description
Methodology:
The study will consist of:
These last two points are realized in the classic framework of the patient care pathway and do not modify the standard procedure.
The comparison between measured and calculated absorbed dose for the validation of the calculation software will be done anonymously. The information collected does not permit the patient identification.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Adult patients (≥ 18 years old) who have a therapeutic interventional radiology procedure for the following anatomical regions:
Patient informed and having expressed his non-opposition to participate in the research
Exclusion criteria
87 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal